Condition: Advanced Melanoma · Sponsor: Immunocore Ltd
The purpose of this study is to evaluate the efficacy and safety of tebentafusp-based regimens, including tebentafusp monotherapy and in combination with anti-PD1 vs investigator choice (including clinical trials of investigational agents, salvage therapy per local standard of care \[SoC\], best supportive care \[BSC\] on protocol survivor follow up) in patients with advanced non-ocular melanoma.
This description comes directly from the study's public registry record.
Immunocore Medical Information · 844-466-8661 · medical.information@immunocore.com
Immunocore Medical Information EU · +00 800-744-51111 · medinfo.eu@immunocore.com
Always discuss trial participation with your own doctor first.
| Mayo Clinic Arizona | Phoenix, Arizona, United States | Recruiting |
| Mayo Clinic Florida | Jacksonville, Florida, United States | Recruiting |
| Orlando Health Cancer Institute | Orlando, Florida, United States | Recruiting |
| Winship Cancer Institute of Emory University | Atlanta, Georgia, United States | Recruiting |
| University of Kansas Cancer Center - Westwood | Westwood, Kansas, United States | Recruiting |
| St Elizabeth Healthcare (St Elizabeth Medical Center) | Edgewood, Kentucky, United States | Recruiting |
| St Elizabeth Healthcare (St Elizabeth Medical | Edgewood, Kentucky, United States | Recruiting |
| Massachusetts General Hospital | Boston, Massachusetts, United States | Recruiting |
| Beth Israel Deaconess Medical Center (BIDMC) | Boston, Massachusetts, United States | Recruiting |
| Dana Farber Cancer Institute | Boston, Massachusetts, United States | Recruiting |
| University of Minnesota Medical Center | Minneapolis, Minnesota, United States | Recruiting |
| Mayo Clinic Minnesota | Rochester, Minnesota, United States | Recruiting |
+ 70 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05549297